MedTrace Logo

Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section

NCT00891540 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-06-23

No results posted yet for this study

Summary

The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % versus Ropivacaine 0.2 % versus Placebo in patients undergoing elective caesarean section.

The hypothesis is that systemic local infiltration will reduce pain and postoperative opioid consumption.

Conditions

  • Pain, Postoperative
  • Postoperative Nausea and Vomiting
  • Cesarean Section

Interventions

DRUG

Ropivacaine

Ropivacaine 0.5%

DRUG

Ropivacaine

Ropivacaine 0.2%

DRUG

placebo

Isotonic NaCl

Sponsors & Collaborators

  • Hvidovre University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00891540 on ClinicalTrials.gov